OMER: Omeros Corp. O‘sish sur’atiga tuzatilgan narx-foyda
Omeros Corporation (OMER) o'zining asosiy ilmiy xodimlarini saqlab qolgan holda, molekulyar kashfiyotlarni tezlashtirish uchun robotlarni joriy qilmoqda. GURU.Markets platformasida PEG koeffitsiyentini kuzatish baholash barqarorligini tasdiqlaydi, bunda 0.00 ushbu metrikaning joriy qiymatini ko'rsatadi. Moliyaviy model litsenziyalar va oftalmologik asbob-uskunalar savdosiga, shuningdek, tomir va nevrologik patologiyalar terapiyasi uchun dori vositalarini ishlab chiqishga asoslangan.
Omeros Corp (OMER) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Omeros Corporation|OMER - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Omeros|OMER - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Omeros|OMER - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Omeros|Oraliq qoplash koeffitsiyenti omeros.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
OMER - Kompaniyaning sof foydasi|Forvard foyda Omeros Corporation|OMER - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Omeros Corp|OMER - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Omeros Corporation|OMER - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Omeros|OMER - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati omeros.com|OMER - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Omeros Corporation
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:OMER (Omeros Corporation)
Omeros Corporation (OMER) kompaniyasini tahlil qilishga konservativ yondashuv bozor qiymatini biznes kengayish dinamikasi bilan solishtirishni talab qiladi. Ushbu ko'rsatkich P/E koeffitsientini foyda o'sish sur'atiga bo'ladi, bu esa PEG koeffitsientining o'rtacha qiymati orqali investor komplement inhibitorlari sohasidagi ilmiy salohiyat uchun haddan tashqari ko'p to'layaptimi yoki yo'qmi, shuni aniqlash imkonini beradi, bu esa kompaniyaning yuqori R&D xarajatlarini hisobga olgan holda juda muhimdir.
Omeros Corporation raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|Neurogene Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|acimmune.com - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning sof foyda o‘sishiga nisbati Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ACOG|Narxning foydaga va o‘sish sur’atiga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SAVA (Cassava)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - PEG multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO (CervoMed, Inc.) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Alterity Therapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc.|PepGen Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - PEG multiplikatori|Klotho Neurosciences (KLTO) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori Passage Bio Inc. (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati bionomics.com.au NEUP|PEG multiplikatori Minerva Neurosciences Inc NERV|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN (Addex Therapeutics, Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Alzamend Neuro Inc. (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati protagenic.com|Pasithea Therapeutics - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori
